Skip to Main Content

Paper Details

Effects of Vitamin D<sub>3</sub> Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL.
Kidney360
3
2022
25(OH), 25(OH)D, 25-hydroxyvitamin D, 25[OH]D, Cancer, Omega-3, PTH, Participants, Vitamin D, cancer, cardiovascular, cardiovascular disease, fatty acids, invasive cancer, parathyroid hormone, participants, secondary hyperparathyroidism, vitamin D, women
Author NameAffiliation
Andrew N HoofnagleKidney Research Institute, University of Washington
Andrew N HoofnagleUniversity of Washington
Samia MoraBrigham and Women's Hospital
Samia MoraBrigham and Women's Hospital, Harvard Medical School
Julie E BuringBrigham and Women's Hospital, Harvard Medical School
Julie E BuringHarvard T.H. Chan School of Public Health
JoAnn E MansonBrigham and Women's Hospital, Harvard Medical School
JoAnn E MansonHarvard T.H. Chan School of Public Health
Ian H de BoerUniversity of Washington
Ian H de BoerKidney Research Institute, University of Washington
Ian H de BoerUniversity of Washington
Ian H de BoerKidney Research Institute, University of Washington
  • 1 - 12

Datasets

Release 1.2